comparemela.com
  1. Home
  2. Live Updates
  3. Joon Lee Truist - Breaking News

Latest Breaking News On - Joon lee truist - Page 3 : comparemela.com

argenx SE (ARGX) Q4 2021 Earnings Call Transcript

ARGX earnings call for the period ending December 31, 2021.

United statesDouglas tsaoRaymond jamesJames gordonDerek archilaJoon lee truistYatin suneja guggenheimDanielle brill raymond jamesCharles pitman redburnAllison bratzelTim van hauwermeirenJoon leeJason butlerAmerica merrill lynchDanielle brillYaron werber cowen

Axsome Therapeutics (AXSM) Q4 2021 Earnings Call Transcript

AXSM earnings call for the period ending December 31, 2021.

United statesHerriot tabuteauMatt kaplanPete stavropoulos cantor fitzgeraldAmanda jonesCharles duncanNick pizzieJoon lee truistJoseph thome cowenJoseph thomeMarc goodmanLori englebertPete stavropoulosJoon leeMark jacobsonMatt kaplan ladenburg thalmann

Global Blood Therapeutics (GBT) Q4 2021 Earnings Call Transcript

GBT earnings call for the period ending December 31, 2021.

United statesFrance generalUnited kingdomCity ofDavid johnsonRaju prasad william blairRaymond jamesJason gerberryKim smith whitleyJoon lee truistSteven immergutAlethia youngAlethia young cantor fitzgeraldDanielle brill raymond jamesJoon leeAmerica merrill lynch

Intellia Therapeutics, Inc (NTLA) Q3 2021 Earnings Call Transcript

NTLA earnings call for the period ending October 3, 2021.

New zealandGena wangSalveen richter goldman sachsGlenn goddardJoon lee truistDavid lebwohlLaura lepp lorenzinoGena wang barclaysSalveen richterLaura sepp lorenzinoMani forooharMaury raycroftJohnm leonardGlenng goddardIan karpMaury raycroft jefferies

argenx SE (ARGX) Q3 2021 Earnings Call Transcript

ARGX earnings call for the period ending September 30, 2021.

United statesUnited kingdomDouglas tsaoRaymond jamesJames gordonRosie turnerJoon lee truistYatin suneja guggenheimWim parysDanielle brill raymond jamesCharles pitman redburnYanan zhuJoon leeJoel beatty bairdEmmanuel papadakisJason butler

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.